O	0	7	Effects
O	8	10	of
O	11	12	a
B-intervention	13	30	Psychoeducational
O	31	43	Intervention
O	44	46	in
B-eligibility	47	55	Patients
I-eligibility	56	60	With
I-eligibility	61	67	Breast
I-eligibility	68	74	Cancer
I-eligibility	75	85	Undergoing
I-eligibility	86	98	Chemotherapy
O	98	99	.

O	100	110	Compelling
O	111	119	evidence
O	120	123	has
O	124	127	yet
O	128	130	to
O	131	133	be
O	134	143	published
O	144	153	regarding
O	154	157	the
O	158	166	positive
O	167	173	effect
O	174	176	of
O	177	194	psychoeducational
O	195	208	interventions
O	209	210	(
O	210	214	PEIs
O	214	215	)
O	216	218	on
O	219	232	psychological
O	233	241	distress
O	242	244	in
O	245	253	patients
O	254	258	with
O	259	265	breast
O	266	272	cancer
O	272	273	.

O	274	277	The
O	278	284	impact
O	285	287	of
O	288	292	PEIs
O	293	295	on
O	296	300	self
O	300	301	-
O	301	309	efficacy
O	309	310	,
O	311	321	resilience
O	321	322	,
O	323	326	and
O	327	334	quality
O	335	337	of
O	338	342	life
O	343	345	is
O	346	350	also
O	351	358	unclear
O	358	359	.

O	360	363	The
O	364	367	aim
O	368	370	of
O	371	375	this
O	376	381	study
O	382	385	was
O	386	388	to
O	389	395	assess
O	396	399	the
O	400	407	effects
O	408	410	of
O	411	412	a
O	413	416	PEI
O	417	419	on
O	420	427	anxiety
O	427	428	,
O	429	439	depression
O	439	440	,
O	441	448	disease
O	448	449	-
O	449	457	specific
O	458	462	care
O	463	472	knowledge
O	472	473	,
O	474	478	self
O	478	479	-
O	479	487	efficacy
O	487	488	,
O	489	499	resilience
O	500	503	and
O	504	511	quality
O	512	514	of
O	515	519	life
O	520	522	in
O	523	531	patients
O	532	536	with
O	537	543	breast
O	544	550	cancer
O	551	557	during
O	558	561	and
O	562	567	after
O	568	580	chemotherapy
O	580	581	.

O	582	585	The
O	586	598	intervention
O	599	602	was
O	603	615	administered
O	616	622	before
O	623	626	and
O	627	633	during
O	634	638	five
O	639	645	rounds
O	646	648	of
O	649	661	chemotherapy
O	662	671	treatment
O	671	672	.

O	673	674	A
O	675	685	randomized
O	686	696	controlled
O	697	702	trial
O	703	706	was
O	707	716	conducted
O	716	717	.

O	718	726	Patients
O	727	731	with
O	732	738	breast
O	739	745	cancer
O	746	747	(
O	747	748	N
O	749	750	=
B-total-participants	751	753	40
O	753	754	)
O	755	759	were
O	760	768	randomly
O	769	777	assigned
O	778	780	to
O	781	787	either
O	788	791	the
O	792	804	experimental
O	805	807	or
B-control	808	815	control
I-control	816	821	group
O	821	822	.

O	823	826	The
O	827	839	experimental
O	840	845	group
O	846	858	participated
O	859	861	in
O	862	865	PEI
O	865	866	,
O	867	868	a
O	869	874	brief
O	875	878	and
O	879	885	highly
O	886	896	structured
O	897	904	program
O	905	915	consisting
O	916	918	of
O	919	922	two
O	923	928	parts
O	928	929	:
O	930	931	(
O	931	932	a
O	932	933	)
O	934	936	an
O	937	948	educational
O	949	955	manual
O	956	960	that
O	961	970	addressed
O	971	981	depression
O	981	982	,
O	983	990	anxiety
O	990	991	,
O	992	999	disease
O	999	1000	-
O	1000	1008	specific
O	1009	1013	care
O	1014	1023	knowledge
O	1023	1024	,
O	1025	1029	self
O	1029	1030	-
O	1030	1038	efficacy
O	1038	1039	,
O	1040	1043	and
O	1044	1054	resilience
O	1055	1058	and
O	1059	1060	(
O	1060	1061	b
O	1061	1062	)
O	1063	1064	a
O	1065	1069	self
O	1069	1070	-
O	1070	1080	assessment
O	1081	1083	of
O	1084	1092	learning
O	1092	1093	.

O	1094	1097	The
O	1098	1105	control
O	1106	1111	group
O	1112	1120	received
O	1121	1125	only
O	1126	1137	traditional
O	1138	1146	pamphlet
O	1147	1156	education
O	1156	1157	.

O	1158	1162	Data
O	1163	1167	were
O	1168	1177	collected
O	1178	1180	at
O	1181	1185	four
O	1186	1190	time
O	1191	1197	points
O	1197	1198	:
O	1199	1205	before
O	1206	1209	the
O	1210	1215	first
O	1216	1228	chemotherapy
O	1229	1236	session
O	1237	1238	(
O	1238	1240	T1
O	1240	1241	)
O	1241	1242	,
O	1243	1249	during
O	1250	1253	the
O	1254	1259	third
O	1260	1272	chemotherapy
O	1273	1280	session
O	1281	1282	(
O	1282	1284	T2
O	1284	1285	)
O	1285	1286	,
O	1287	1293	during
O	1294	1297	the
O	1298	1303	fifth
O	1304	1316	chemotherapy
O	1317	1324	session
O	1325	1326	(
O	1326	1328	T3
O	1328	1329	)
O	1329	1330	,
O	1331	1334	and
O	1335	1337	at
O	1338	1339	2
O	1340	1345	weeks
O	1346	1351	after
O	1352	1355	the
O	1356	1361	final
O	1362	1374	chemotherapy
O	1375	1382	session
O	1383	1384	(
O	1384	1386	T4
O	1386	1387	)
O	1387	1388	.

B-outcome	1389	1396	Anxiety
O	1396	1397	,
B-outcome	1398	1408	depression
O	1408	1409	,
B-outcome	1410	1420	resilience
O	1420	1421	,
O	1422	1425	and
B-outcome	1426	1433	quality
I-outcome	1434	1436	of
I-outcome	1437	1441	life
O	1442	1444	in
O	1445	1448	the
O	1449	1461	experimental
O	1462	1467	group
O	1468	1474	showed
O	1475	1486	significant
O	1487	1498	differences
O	1499	1501	at
O	1502	1504	T4
O	1504	1505	.

O	1506	1517	Significant
O	1518	1529	differences
O	1530	1536	became
O	1537	1545	apparent
O	1546	1548	at
O	1549	1551	T2
O	1552	1555	for
B-outcome	1556	1565	knowledge
O	1566	1569	and
O	1570	1572	at
O	1573	1575	T3
O	1576	1579	for
B-outcome	1580	1584	self
I-outcome	1584	1585	-
I-outcome	1585	1593	efficacy
O	1593	1594	.

O	1595	1598	The
B-outcome	1599	1606	effects
I-outcome	1607	1609	of
I-outcome	1610	1619	knowledge
O	1619	1620	,
B-outcome	1621	1631	resilience
O	1631	1632	,
O	1633	1636	and
B-outcome	1637	1644	quality
I-outcome	1645	1647	of
I-outcome	1648	1652	life
O	1653	1661	remained
O	1662	1673	significant
O	1674	1678	when
O	1679	1684	group
O	1685	1688	and
O	1689	1693	time
O	1694	1706	interactions
O	1707	1711	were
O	1712	1720	included
O	1721	1723	in
O	1724	1727	the
O	1728	1733	model
O	1733	1734	,
O	1735	1742	showing
O	1743	1744	a
O	1745	1753	positive
O	1754	1766	relationship
O	1767	1774	between
O	1775	1778	PEI
O	1779	1782	and
O	1783	1786	the
O	1787	1796	variables
O	1797	1799	of
O	1800	1809	knowledge
O	1809	1810	,
O	1811	1821	resilience
O	1821	1822	,
O	1823	1826	and
O	1827	1834	quality
O	1835	1837	of
O	1838	1842	life
O	1842	1843	.

O	1844	1848	Face
O	1848	1849	-
O	1849	1851	to
O	1851	1852	-
O	1852	1856	face
O	1857	1860	PEI
O	1861	1864	for
O	1865	1873	patients
O	1874	1878	with
O	1879	1885	breast
O	1886	1892	cancer
O	1893	1895	is
O	1896	1907	potentially
O	1908	1917	effective
O	1918	1920	in
O	1921	1930	improving
O	1931	1940	knowledge
O	1940	1941	,
O	1942	1952	resilience
O	1952	1953	,
O	1954	1957	and
O	1958	1965	quality
O	1966	1968	of
O	1969	1973	life
O	1974	1980	during
O	1981	1984	and
O	1985	1990	after
O	1991	2003	chemotherapy
O	2003	2004	.

O	2005	2007	In
O	2008	2011	the
O	2012	2019	current
O	2020	2025	study
O	2025	2026	,
O	2027	2030	PEI
O	2031	2044	significantly
O	2045	2053	improved
O	2054	2061	disease
O	2062	2066	care
O	2067	2077	techniques
O	2077	2078	,
O	2079	2086	reduced
O	2087	2099	chemotherapy
O	2099	2100	-
O	2100	2107	related
O	2108	2118	discomfort
O	2118	2119	,
O	2120	2123	and
O	2124	2132	improved
O	2133	2140	quality
O	2141	2143	of
O	2144	2148	life
O	2149	2152	for
O	2153	2165	participants
O	2166	2168	in
O	2169	2172	the
O	2173	2185	experimental
O	2186	2191	group
O	2191	2192	.
